Published in J Aerosol Med Pulm Drug Deliv on October 17, 2016
Differentiation of receptor systems activated by sympathomimetic amines. Nature (1967) 11.46
Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med (2007) 6.54
Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis (1981) 4.16
Large porous particles for pulmonary drug delivery. Science (1997) 3.35
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Delivery of biotherapeutics by inhalation aerosol. Crit Rev Ther Drug Carrier Syst (1995) 1.66
The inhalation of drugs: advantages and problems. Respir Care (2005) 1.64
Inhaled insulin: a breath of fresh air? A review of inhaled insulin. Clin Ther (2014) 1.54
The history of Ephedra (ma-huang). J R Coll Physicians Edinb (2011) 1.53
Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest (1983) 1.50
Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol (1999) 1.44
A review of the development of Respimat Soft Mist Inhaler. Int J Pharm (2004) 1.32
The science of nebulised drug delivery. Thorax (1997) 1.28
Administration of cortisone by the aerosol method in the treatment of bronchial asthma. N Engl J Med (1951) 1.25
Aerosolized steroids in bronchial asthma. J Allergy (1958) 1.17
A tube spacer to improve inhalation of drugs from pressurised aerosols. Br Med J (1979) 1.13
Dry powder inhalers for pulmonary drug delivery. Expert Opin Drug Deliv (2004) 1.13
Dry powder aerosols. I. A new powder inhalation device. J Pharm Sci (1971) 1.13
History of aerosol therapy: liquid nebulization to MDIs to DPIs. Respir Care (2005) 1.11
Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J (1975) 1.11
The Diskus: a review of its position among dry powder inhaler devices. Int J Clin Pract (2007) 1.09
High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am J Epidemiol (2006) 1.05
Air and soul: the science and application of aerosol therapy. Respir Care (2010) 1.04
Dry powder inhalers: an overview. Respir Care (2005) 1.02
Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ (2002) 1.02
Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma. Allergy (2013) 0.96
The failure of exubera: are we beating a dead horse? J Diabetes Sci Technol (2008) 0.95
The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm Res (2006) 0.92
Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm Res (2004) 0.92
Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm (1999) 0.89
Delivery options and devices for aerosolized therapeutics. Chest (2001) 0.89
Medihaler therapy for bronchial asthma; a new type of aerosol therapy. Postgrad Med (1956) 0.89
Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand? Expert Opin Drug Deliv (2015) 0.86
Inhalation therapy: an historical review. Prim Care Respir J (2007) 0.86
Safety of inhaled proteins for therapeutic use. J Aerosol Med (1998) 0.85
Advances in metered dose inhaler technology: hardware development. AAPS PharmSciTech (2013) 0.83
Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med (1999) 0.83
Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial. Vaccine (2014) 0.81
The CFC to HFA transition and its impact on pulmonary drug development. Respir Care (2005) 0.81
Novel Aerosol Delivery Devices. Semin Respir Crit Care Med (2015) 0.79
The evolution of spacers and valved holding chambers. J Aerosol Med Pulm Drug Deliv (2014) 0.79
The ascent of pulmonary drug delivery. J Pharm Sci (2000) 0.79
Forced degradation studies of corticosteroids with an alumina-steroid-ethanol model for predicting chemical stability and degradation products of pressurized metered-dose inhaler formulations. J Pharm Sci (2012) 0.79
Why do medical nebulizers differ in their output and particle size characteristics? J Aerosol Med (1994) 0.78
Twenty years of HFA pMDI patents: facts and perspectives. J Pharm Pharmacol (2011) 0.77
Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate. Int J Pharm (2008) 0.77
The clinical pharmacology of a herbal asthma cigarette. Br J Clin Pharmacol (1980) 0.77
The inhalation of penicillin dust; its proper role in the management of respiratory infections. Am Pract Dig Treat (1949) 0.76
Threat of pandemic brings flu drug back to life. Nat Med (2005) 0.76
The Carbolic smoke ball. Pharm Hist (Lond) (1984) 0.76
Principles and, practice of aerosol therapy of the lungs and bronchi. Ann Allergy (1947) 0.76
The early history of anaesthesia in Canada: the introduction of ether to upper Canada, 1847. Can Anaesth Soc J (1977) 0.76
Medicinal aspects of opium as described in Avicenna's Canon of Medicine. Acta Med Hist Adriat (2013) 0.76
Black henbane and its toxicity - a descriptive review. Avicenna J Phytomed (2014) 0.76
New and Emerging Treatments for Cystic Fibrosis. Drugs (2015) 0.76